Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Versartis sell klostergang

Start price
€17.32
21.09.17 / 50%
Target price
€64.94
22.09.17
Performance (%)
0.00%
End price
€16.78
22.09.17
Summary
This prediction ended on 22.09.17 with a price of €16.78. klostergang's SELL prediction for Versartis closed completely unchanged. klostergang has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Versartis - - - -
iShares Core DAX® -1.611% 3.135% 15.880% 15.652%
iShares Nasdaq 100 -0.500% 0.775% 20.054% 32.402%
iShares Nikkei 225® -1.483% 4.610% 11.154% -1.568%
iShares S&P 500 -0.501% 1.914% 21.016% 37.314%

Comments by klostergang for this prediction

In the thread Versartis diskutieren
Prediction Sell
Perf. (%) 0.00%
Target price 64.944
Change
Ends at 22.09.17

Versartis' lead candidate VRS-317 flunks late-stage study

Thinly traded small cap Versartis (NASDAQ:VSAR) is set for a tumble after reporting negative results in a Phase 3 clinical trial, VELOCITY, assessing lead candidate somavaratan (VRS-317) for the treatment of pediatric growth hormone deficiency.


Prediction Sell
Perf. (%) 0.00%
Target price 64.944
Change
Ends at 22.09.17

(Zielkurs erreicht)